Serum Institute to make up to 100 million COVID-19 vaccine doses for India, low-income countries by 2021

By |2024-12-09T10:59:16-03:00August 10, 2020|News|

Australia approves remdesivir as first treatment option for COVID-19

By |2024-12-09T10:59:15-03:00August 2, 2020|News|

Trial of Oxford COVID-19 vaccine starts in Brazil

By |2024-12-09T10:59:14-03:00July 15, 2020|News|

Merck CEO Frazier says COVID-19 vaccine hype a ‘grave disservice’ to the public

By |2024-12-09T10:59:13-03:00July 14, 2020|News|

Remdesivir out-of-stock, as other manufacturers start producing

By |2024-12-09T10:59:11-03:00July 4, 2020|News|